1.Cheng, G et al. (2016) Mosquito defense strategies against viral infection. Trends in Parasitology 32, 177–186.
2.Gaunt, MW et al. (2001) Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. The Journal of General Virology 82, 1867–1876.
3.Weaver, SC and Reisen, WK (2010) Present and future arboviral threats. Antiviral Research 85, 328.
4.Gubler, DJ (1998) Resurgent vector-borne diseases as a global health problem. Emerging Infectious Diseases 4, 442–450.
5.Leta, S et al. (2018) Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus. International Journal of Infectious Diseases 67, 25–35.
6.Bhatt, S et al. (2013) The global distribution and burden of dengue. Nature 496, 504–507.
7.The Pan American Health Organization [PAHO]/World Health Organization [WHO] (2017) Zika cases and congenital syndrome associated with Zika virus reported by countries and territories in the Americas, 2015–2017 Cumulative cases.
8.Gao, GF (2018) From ‘A'IV to ‘Z'IKV: attacks from emerging and re-emerging pathogens. Cell 172, 1157–1159.
9.Parra, B et al. (2016) Guillain-Barre syndrome associated with Zika virus infection in Colombia. New England Journal of Medicine 375, 1513–1523.
10.Iranpour, M et al. (2016) Apoptosis, autophagy and unfolded protein response pathways in arbovirus replication and pathogenesis. Expert Reviews in Molecular Medicine 18, e1.
11.Lessler, J et al. (2016) Assessing the global threat from Zika virus. Science 353, aaf8160.
12.Grinev, A et al. (2015) The global ecology and epidemiology of West Nile virus. BioMed Research International 2015, 376230.
13.Ruckert, C et al. (2017) Impact of simultaneous exposure to arboviruses on infection and transmission by Aedes aegypti mosquitoes. Nature Communications 8, 15412.
14.Nguyen, NM et al. (2013) Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes. Proceedings of the National Academy of Sciences, USA 110, 9072–9077.
15.Wagar, ZL et al. (2017) Low density lipopolyprotein inhibits flavivirus acquisition in Aedes aegypti. Insect Molecular Biology 26, 734–742.
16.Bottino-Rojas, V et al. (2015) Heme signaling impacts global gene expression, immunity and dengue virus infectivity in Aedes aegypti. PLoS One 10, e0135985.
17.Zhu, Y et al. (2017) Blood meal acquisition enhances arbovirus replication in mosquitoes through activation of the GABAergic system. Nature Communications 8, 1262.
18.Liu, J et al. (2016) Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes. Nature Microbiology 1, 16087.
19.Liu, Y et al. (2017) Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes. Nature 545, 482–486.
20.Merkling, SH and van Rij, RP (2013) Beyond RNAi: antiviral defense strategies in Drosophila and mosquito. Journal of Insect Physiology 59, 159–170.
21.Blair, CD and Olson, KE (2015) The role of RNA interference (RNAi) in arbovirus-vector interactions. Viruses 7, 820–843.
22.Franz, AW et al. (2014) Fitness impact and stability of a transgene conferring resistance to dengue-2 virus following introgression into a genetically diverse Aedes aegypti strain. PLoS Neglected Tropical Diseases 8, e2833.
23.Sanchez-Vargas, I et al. (2009) Dengue virus type 2 infections of Aedes aegypti are modulated by the mosquito's RNA interference pathway. PLoS Pathogens 5, e1000299.
24.Carissimo, G et al. (2015) Antiviral immunity of Anopheles gambiae is highly compartmentalized, with distinct roles for RNA interference and gut microbiota. Proceedings of the National Academy of Sciences of the United States of America 112, E176–E185.
25.Xi, Z et al. (2008) The Aedes aegypti toll pathway controls dengue virus infection. PLoS Pathogens 4, e1000098.
26.Souza-Neto, JA et al. (2009) An evolutionary conserved function of the JAK-STAT pathway in anti-dengue defense. Proceedings of the National Academy of Sciences, USA 106, 17841–17846.
27.Ramirez, JL et al. (2014) Chromobacterium Csp_P reduces malaria and dengue infection in vector mosquitoes and has entomopathogenic and in vitro anti-pathogen activities. PLoS Pathogens 10, e1004398.
28.Saraiva, RG et al. (2018) Aminopeptidase secreted by Chromobacterium sp. Panama inhibits dengue virus infection by degrading the E protein. PLoS Neglected Tropical Diseases 12, e0006443.
29.Ramirez, JL et al. (2012) Reciprocal tripartite interactions between the Aedes aegypti midgut microbiota, innate immune system and dengue virus influences vector competence. PLoS Neglected Tropical Diseases 6, e1561.
30.Dong, Y et al. (2012) The entomopathogenic fungus Beauveria bassiana activate toll and JAK-STAT pathway-controlled effector genes and anti-dengue activity in Aedes aegypti. Insect Biochemistry and Molecular Biology 42, 126–132.
31.Apte-Deshpande, A et al. (2012) Serratia odorifera a midgut inhabitant of Aedes aegypti mosquito enhances its susceptibility to dengue-2 virus. PLoS One 7, e40401.
32.Anglero-Rodriguez, YI et al. (2017) An Aedes aegypti-associated fungus increases susceptibility to dengue virus by modulating gut trypsin activity. Elife 6, e28844.
33.Franz, AW et al. (2015) Tissue barriers to arbovirus infection in mosquitoes. Viruses 7, 3741–3767.
34.Barrows, NJ et al. (2018) Biochemistry and molecular biology of Flaviviruses. Chemical Reviews 118, 4448–4482.
35.Cheng, G et al. (2010) A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes. Cell 142, 714–725.
36.Liu, Y et al. (2014) Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention. PLoS Pathogens 10, e1003931.
37.Kuadkitkan, A et al. (2010) Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells. Virology 406, 149–161.
38.Salas-Benito, J et al. (2007) Evidence that the 45-kD glycoprotein, part of a putative dengue virus receptor complex in the mosquito cell line C6/36, is a heat-shock related protein. The American Journal of Tropical Medicine and Hygiene 77, 283–290.
39.Sakoonwatanyoo, P et al. (2006) Growth and production of the dengue virus in C6/36 cells and identification of a laminin-binding protein as a candidate serotype 3 and 4 receptor protein. Intervirology 49, 161–172.
40.Londono-Renteria, B et al. (2015) Dengue virus infection of Aedes aegypti requires a putative cysteine rich venom protein. PLoS Pathogens 11, e1005202.
41.Rose, PP et al. (2011) Natural resistance-associated macrophage protein (NRAMP) is a cellular receptor for Sindbis virus in both insect and mammalian hosts. Cell Host & Microbe 10, 97–104.
42.Samuel, GH et al. (2018) Antiviral immunity and virus-mediated antagonism in disease vector mosquitoes. Trends in Microbiology 26, 447–461.
43.Kakumani, PK et al. (2013) Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor. Journal of Virology 87, 8870–8883.
44.Mathur, K et al. (2016) Analysis of chikungunya virus proteins reveals that non-structural proteins nsP2 and nsP3 exhibit RNA interference (RNAi) suppressor activity. Scientific Reports 6, 38065.
45.Göertz, GP et al. (2016) Noncoding subgenomic flavivirus RNA is processed by the mosquito RNA interference machinery and determines west Nile virus transmission by Culex pipiens mosquitoes. Journal of Virology 90, 10145–10159.
46.Moon, SL et al. (2015) Flavivirus sfRNA suppresses antiviral RNA interference in cultured cells and mosquitoes and directly interacts with the RNAi machinery. Virology 485, 322–329.
47.Pompon, J et al. (2017) Dengue subgenomic flaviviral RNA disrupts immunity in mosquito salivary glands to increase virus transmission. PLoS Pathogens 13, e1006535.
48.Parikh, GR et al. (2009) A haemocyte tropism for an arbovirus. The Journal of General Virology 90, 292–296.
49.Goic, B et al. (2016) Virus-derived DNA drives mosquito vector tolerance to arboviral infection. Nature Communications 7, 12410.
50.Christensen, BM et al. (2005) Melanization immune responses in mosquito vectors. Trends in Parasitology 21, 192–199.
51.Cerenius, L and Soderhall, K (2004) The prophenoloxidase-activating system in invertebrates. Immunological Reviews 198, 116–126.
52.Rodriguez-Andres, J et al. (2012) Phenoloxidase activity acts as a mosquito innate immune response against infection with Semliki Forest virus. PLoS Pathogens 8, e1002977.
53.Xiao, X et al. (2015) A neuron-specific antiviral mechanism prevents lethal flaviviral infection of mosquitoes. PLoS Pathogens 11, e1004848.
54.Xiao, X et al. (2014) Complement-related proteins control the flavivirus infection of Aedes aegypti by inducing antimicrobial peptides. PLoS Pathogens 10, e1004027.
55.Blandin, S et al. (2004) Complement-like protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles gambiae. Cell 116, 661–670.
56.Shokal, U and Eleftherianos, I (2017) Evolution and function of thioester-containing proteins and the complement system in the innate immune response. Frontiers in Immunology 8, 759.
57.Kingsolver, MB et al. (2013) Insect antiviral innate immunity: pathways, effectors, and connections. Journal of Molecular Biology 425, 4921–4936.
58.Tassetto, M et al. (2017) Circulating immune cells mediate a systemic RNAi-based adaptive antiviral response in drosophila. Cell 169, 314–325, e313.
59.Goic, B et al. (2013) RNA-mediated interference and reverse transcription control the persistence of RNA viruses in the insect model Drosophila. Nature Immunology 14, 396–403.
60.Cerny, D et al. (2014) Selective susceptibility of human skin antigen presenting cells to productive dengue virus infection. PLoS Pathogens 10, e1004548.
61.Schmid, MA and Harris, E (2014) Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication. PLoS Pathogens 10, e1004541.
62.Hamel, R et al. (2015) Biology of Zika virus infection in human skin cells. Journal of Virology 89, 8880–8896.
63.Blackley, S et al. (2007) Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. Journal of Virology 81, 13325–13334.
64.Styer, LM et al. (2011) Mosquito saliva causes enhancement of West Nile virus infection in mice. Journal of Virology 85, 1517–1527.
65.Cox, J et al. (2012) Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. Journal of Virology 86, 7637–7649.
66.Surasombatpattana, P et al. (2014) Aedes aegypti saliva contains a prominent 34-kDa protein that strongly enhances dengue virus replication in human keratinocytes. The Journal of Investigative Dermatology 134, 281–284.
67.Schneider, BS et al. (2004) Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection. Viral Immunology 17, 565–573.
68.Jin, L et al. (2018) Salivary factor LTRIN from Aedes aegypti facilitates the transmission of Zika virus by interfering with the lymphotoxin-beta receptor. Nature Immunology 19, 342–353.
69.Conway, MJ et al. (2014) Mosquito saliva serine protease enhances dissemination of dengue virus into the mammalian host. Journal of Virology 88, 164–175.
70.Pingen, M et al. (2016) Host inflammatory response to mosquito bites enhances the severity of arbovirus infection. Immunity 44, 1455–1469.
71.Schneider, BS et al. (2010) Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during west Nile virus infection. PLoS One 5, e11704.